NCT01304706View on ClinicalTrials.gov

Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

November 30, 2013

Conditions

Diabetic Macular Edema

Interventions

DRUG

Fluocinolone Acetonide

0.2 μg/day

Trial Locations (1)

Unknown

Alpharetta

Sponsors

Lead Sponsor

Alimera Sciences

All Listed Sponsors

lead

Alimera Sciences

INDUSTRY